Thermo Fisher Hits $1.34 Billion Volume Climbs to 75th in Market Activity Amid Biotech Push

Thermo Fisher Scientific (TMO) closed on October 6, 2025, with a trading volume of $1.34 billion, ranking 75th in market activity for the day. The stock’s performance reflected modest gains amid broader market fluctuations, though the company’s focus on life sciences and diagnostics remained a key narrative for investors.

Recent developments highlighted Thermo’s strategic investments in genomic research and its expanded partnership with academic institutions for AI-driven drug discovery. These moves underscored the company’s long-term positioning in high-growth biotech segments. Analysts noted that while short-term volatility remained tied to macroeconomic factors, the firm’s R&D pipeline and market share in diagnostic testing continued to attract institutional attention.

To run this back-test accurately, additional parameters are required: defining the market universe (e.g., U.S. equities only), specifying whether “top 500 by daily trading volume” refers to share count or dollar value, confirming the portfolio rebalancing frequency (e.g., daily equal-weighting), and determining whether transaction costs or slippage should be factored in. Once these details are clarified, the back-test can be executed from January 3, 2022, through the current date.